NL8004361A - Homogeen fibroblasten-interferon en de bereiding daarvan. - Google Patents

Homogeen fibroblasten-interferon en de bereiding daarvan. Download PDF

Info

Publication number
NL8004361A
NL8004361A NL8004361A NL8004361A NL8004361A NL 8004361 A NL8004361 A NL 8004361A NL 8004361 A NL8004361 A NL 8004361A NL 8004361 A NL8004361 A NL 8004361A NL 8004361 A NL8004361 A NL 8004361A
Authority
NL
Netherlands
Prior art keywords
interferon
column
siog
water
human fibroblast
Prior art date
Application number
NL8004361A
Other languages
English (en)
Dutch (nl)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NL8004361A publication Critical patent/NL8004361A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/565IFN-beta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NL8004361A 1979-07-31 1980-07-30 Homogeen fibroblasten-interferon en de bereiding daarvan. NL8004361A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US6237179A 1979-07-31 1979-07-31
US6237179 1979-07-31
US13063580A 1980-03-14 1980-03-14
US13063580 1980-03-14

Publications (1)

Publication Number Publication Date
NL8004361A true NL8004361A (nl) 1981-02-03

Family

ID=26742182

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8004361A NL8004361A (nl) 1979-07-31 1980-07-30 Homogeen fibroblasten-interferon en de bereiding daarvan.

Country Status (33)

Country Link
US (1) US5015730A (fi)
JP (1) JPH02138226A (fi)
AR (1) AR229931A1 (fi)
AT (1) AT372387B (fi)
AU (1) AU536274B2 (fi)
CA (1) CA1146468A (fi)
CH (1) CH648331A5 (fi)
DE (1) DE3028919A1 (fi)
DK (1) DK159825C (fi)
DO (1) DOP1980002948A (fi)
ES (1) ES8200560A1 (fi)
FI (1) FI70721C (fi)
FR (1) FR2462167B1 (fi)
GB (1) GB2055384B (fi)
HK (1) HK40384A (fi)
HU (1) HU185382B (fi)
IE (1) IE50075B1 (fi)
IL (1) IL60697A (fi)
IT (1) IT1132269B (fi)
KE (1) KE3364A (fi)
LU (1) LU82673A1 (fi)
MC (1) MC1337A1 (fi)
MY (1) MY8500274A (fi)
NL (1) NL8004361A (fi)
NO (1) NO151158C (fi)
NZ (1) NZ194495A (fi)
PH (2) PH17738A (fi)
PT (1) PT71625B (fi)
RO (1) RO81474B (fi)
SE (1) SE466290B (fi)
YU (1) YU193480A (fi)
ZA (1) ZA803943B (fi)
ZW (1) ZW17980A1 (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2687995B2 (ja) 1980-04-03 1997-12-08 バイオゲン インコーポレイテッド Dna配列、組替えdna分子およびヒト繊維芽細胞インターフェロン様ポリペプチドの製造方法
FR2490675B1 (fr) * 1980-09-25 1985-11-15 Genentech Inc Production microbienne d'interferon de fibroplaste humain
ZA83768B (en) * 1982-03-01 1983-10-26 Hoffmann La Roche Homogeneous human immune interferon and process therefor
US4966843A (en) * 1982-11-01 1990-10-30 Cetus Corporation Expression of interferon genes in Chinese hamster ovary cells
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
US4530787A (en) * 1984-03-28 1985-07-23 Cetus Corporation Controlled oxidation of microbially produced cysteine-containing proteins
US4894330A (en) * 1986-12-23 1990-01-16 Cetus Corporation Purification of recombinant beta-interferon incorporating RP-HPLC
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
US20030026779A1 (en) * 1999-10-15 2003-02-06 Liming Yu Treatment of tumors and viral infections with a hybrid conjugate of interferon and an immunoglobulin Fc
US20050002902A1 (en) * 1995-12-28 2005-01-06 Liming Yu Hybrid with interferon-alpha and an immunoglobulin Fc for treatment of tumors and viral infections
US20080219952A1 (en) 2005-08-26 2008-09-11 Ares Trading S.A. Process For the Preparation of Glycosylated Interferon Beta
EP1960419B1 (en) 2005-12-09 2016-03-16 Ares Trading S.A. Method for purifying fsh or a fsh mutant
AU2008314687A1 (en) * 2007-10-22 2009-04-30 Merck Serono S.A. Method for purifying Fc-fusion proteins
DE102009032179A1 (de) 2009-07-07 2011-01-13 Biogenerix Ag Verfahren zur Reinigung von Interferon beta

Also Published As

Publication number Publication date
IE801589L (en) 1981-01-31
FI70721C (fi) 1986-10-06
DK328880A (da) 1981-02-01
PH17738A (en) 1984-11-23
NZ194495A (en) 1984-07-31
JPH02138226A (ja) 1990-05-28
SE466290B (sv) 1992-01-27
DK159825C (da) 1991-04-29
DK159825B (da) 1990-12-10
MY8500274A (en) 1985-12-31
FI70721B (fi) 1986-06-26
RO81474A (ro) 1983-04-29
PT71625A (en) 1980-08-01
AU6091480A (en) 1981-02-05
IL60697A (en) 1984-04-30
PT71625B (en) 1981-12-17
ES493849A0 (es) 1981-11-16
ES8200560A1 (es) 1981-11-16
KE3364A (en) 1984-02-03
IL60697A0 (en) 1980-09-16
FR2462167A1 (fr) 1981-02-13
GB2055384B (en) 1983-08-10
IT8023801A0 (it) 1980-07-30
LU82673A1 (fr) 1982-02-17
CA1146468A (en) 1983-05-17
DOP1980002948A (es) 1989-04-20
GB2055384A (en) 1981-03-04
IE50075B1 (en) 1986-02-05
ZA803943B (en) 1981-06-24
NO151158C (no) 1985-02-20
ATA395080A (de) 1983-02-15
HU185382B (en) 1985-01-28
DE3028919C2 (fi) 1988-02-18
SE8005498L (sv) 1981-02-01
FI802400A (fi) 1981-02-01
IT1132269B (it) 1986-07-02
NO151158B (no) 1984-11-12
CH648331A5 (de) 1985-03-15
RO81474B (ro) 1983-04-30
HK40384A (en) 1984-05-18
US5015730A (en) 1991-05-14
AU536274B2 (en) 1984-05-03
AT372387B (de) 1983-09-26
PH18479A (en) 1985-07-18
NO802297L (no) 1981-02-02
FR2462167B1 (fr) 1985-07-05
DE3028919A1 (de) 1981-02-19
MC1337A1 (fr) 1981-04-21
YU193480A (en) 1984-04-30
AR229931A1 (es) 1984-01-31
ZW17980A1 (en) 1981-03-18

Similar Documents

Publication Publication Date Title
NL8004361A (nl) Homogeen fibroblasten-interferon en de bereiding daarvan.
US4289689A (en) Preparation of homogeneous human fibroblast interferon
NL193085C (nl) Werkwijze voor de winning van humaan leucocyten-interferon, alsmede farmaceutisch preparaat met het aldus verkregen interferon.
Said et al. Isolation from porcine‐intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon
Cutler et al. Purification of a multipotential colony-stimulating factor from pokeweed mitogen-stimulated mouse spleen cell conditioned medium.
US5573936A (en) Process for purifying echinocandin B deacylase
Böhlen et al. Human brain fibroblast growth factor: Isolation and partial chemical characterization
EP0131816A1 (en) Modified (1-56) beta interferons
US4765903A (en) Purification of monomeric interferon
GB2119383A (en) Homogeneous human immune interferon and process therefor
BROECKE et al. Characterization of interferon-α binding sites on human cell lines
US4617378A (en) Purification of biologically active human immune interferon
Fantes Further purification of chick interferon
JPH031320B2 (fi)
EP0411503A1 (en) Process for identifying and synthesizing binding sites of interacting proteins
WO1995024474A1 (en) Bone morphogenic protein-10
Rubinstein et al. [67] Purification and characterization of human leukocyte interferons by high-performance liquid chromatography
KR840001516B1 (ko) 인체 섬유아세포 인터페론의 제조방법
Körner et al. Simple preparative two-step purification of interleukin-2 from culture medium of lectin stimulated normal human lymphocytes
Yip et al. Isolation of the epidermal growth factor from the shrew submaxillary gland
IE63323B1 (en) Purification of gm-csf
EP0396555A1 (en) PURIFICATION OF INTERFERON MONOMER.
Smith et al. [26] Purification of multiplication-stimulating activity carrier protein
JPH06263796A (ja) 生理活性ペプチド

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
A85 Still pending on 85-01-01
BB A search report has been drawn up
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: HOFFMANN-LA ROCHE AG. F. -

BV The patent application has lapsed